Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
Gross Profit
Societal CDMO Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Societal CDMO Inc
NASDAQ:SCTL
|
Gross Profit
$18.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Gross Profit
$59.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Gross Profit
$34.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Gross Profit
$38.8B
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Merck & Co Inc
NYSE:MRK
|
Gross Profit
$46B
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
Eli Lilly and Co
NYSE:LLY
|
Gross Profit
$28.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
See Also
What is Societal CDMO Inc's Gross Profit?
Gross Profit
18.1m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Gross Profit amounts to 18.1m USD.
What is Societal CDMO Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
-12%
Over the last year, the Gross Profit growth was -22%. The average annual Gross Profit growth rates for Societal CDMO Inc have been 14% over the past three years , -12% over the past five years .